206 related articles for article (PubMed ID: 17518772)
1. Cell adhesion protein expression in melanocytic matricoma.
Soler AP; Burchette JL; Bellet JS; Olson JA
J Cutan Pathol; 2007 Jun; 34(6):456-60. PubMed ID: 17518772
[TBL] [Abstract][Full Text] [Related]
2. Where pigmented pilomatricoma and melanocytic matricoma collide.
Tallon B; Cerroni L
Am J Dermatopathol; 2010 Dec; 32(8):769-73. PubMed ID: 20881831
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
4. Melanocytic matricoma in a dog.
Saito S; Suzuki K; Shibuya H; Yamaguchi T; Sato T
Vet Pathol; 2005 Jul; 42(4):499-502. PubMed ID: 16006611
[TBL] [Abstract][Full Text] [Related]
5. An unusual composite pilomatrix carcinoma with intralesional melanocytes: differential diagnosis, immunohistochemical evaluation, and review of the literature.
Jani P; Chetty R; Ghazarian DM
Am J Dermatopathol; 2008 Apr; 30(2):174-7. PubMed ID: 18360125
[TBL] [Abstract][Full Text] [Related]
6. Melanocytic matricoma: case confirmation of a recently described entity.
Williams CM; Bozner P; Oliveri CV; Horenstein MG
J Cutan Pathol; 2003 Apr; 30(4):275-8. PubMed ID: 12680961
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
8. Melanocytic matricoma with melanocytic atypia: report of a unique case and review of the literature.
Zussman J; Sheth S; Ra SH; Binder SW
Am J Dermatopathol; 2011 Jul; 33(5):508-12. PubMed ID: 21252635
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.
Kizawa K; Toyoda M; Ito M; Morohashi M
Br J Dermatol; 2005 Feb; 152(2):314-20. PubMed ID: 15727645
[TBL] [Abstract][Full Text] [Related]
10. A tumor with composite pilo-folliculosebaceous differentiation harboring a recently described new entity--melanocytic matricoma.
Rizzardi C; Brollo A; Colonna A; Brutto RL; Melato M
Am J Dermatopathol; 2002 Dec; 24(6):493-7. PubMed ID: 12454602
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic matricoma. Report of a further case with clinicopathological and immunohistochemical findings, differential diagnosis and review of the literature.
Cartaginese F; Sidoni A
Histol Histopathol; 2010 Jun; 25(6):713-7. PubMed ID: 20376777
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
[TBL] [Abstract][Full Text] [Related]
13. Expression of cadherin/catenin cell--cell adhesion molecules in a onychomatricoma.
Burchette JL; Pham TT; Higgins SP; Cook JL; Soler AP
Int J Surg Pathol; 2008 Jul; 16(3):349-53. PubMed ID: 18573792
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
15. Melanocytic matricoma: a report of two cases of a new entity.
Carlson JA; Healy K; Slominski A; Mihm MC
Am J Dermatopathol; 1999 Aug; 21(4):344-9. PubMed ID: 10446775
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
17. Expression of hard alpha-keratins in pilomatrixoma, craniopharyngioma, and calcifying odontogenic cyst.
Kusama K; Katayama Y; Oba K; Ishige T; Kebusa Y; Okazawa J; Fukushima T; Yoshino A
Am J Clin Pathol; 2005 Mar; 123(3):376-81. PubMed ID: 15716233
[TBL] [Abstract][Full Text] [Related]
18. Malignant Melanocytic Matricoma: A Report of 2 Cases and Review of the Literature.
Ardakani NM; Palmer DL; Wood BA
Am J Dermatopathol; 2016 Jan; 38(1):33-8. PubMed ID: 26730694
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.
Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M
J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608
[TBL] [Abstract][Full Text] [Related]
20. Matrical Carcinoma With Melanocytic Proliferation and Prominent Squamoid Whorls.
Villada G; Romagosa R; Miteva M; Romanelli P
Am J Dermatopathol; 2016 Jan; 38(1):e11-4. PubMed ID: 26275314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
